Early diagnosis of infantile-onset lysosomal acid lipase deficiency in the advent of available enzyme replacement therapy
Abstract Background Lysosomal acid lipase deficiency (LAL-D) is an autosomal recessive disorder that can present as a severe, infantile form also known as Wolman disease. We sought to determine the outcomes and clinical needs of infants diagnosed with LAL-D, treated with enzyme replacement therapy (...
Main Authors: | Jennifer L. Cohen, Jessica Burfield, Karen Valdez-Gonzalez, Angela Samuels, Arianna K. Stefanatos, Marc Yudkoff, Helio Pedro, Can Ficicioglu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-08-01
|
Series: | Orphanet Journal of Rare Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13023-019-1129-y |
Similar Items
-
Dissecting cell type–specific impact in lysosomal acid lipase deficiency–associated disorders
by: Marit Westerterp, et al.
Published: (2023-12-01) -
CT features of Wolman disease (lysosomal acid lipase enzyme deficiency) – A case report
by: Naqibullah Foladi, MD, et al.
Published: (2021-10-01) -
Lysosomal acid lipase deficiency in pediatric patients: a scoping review
by: Camila da Rosa Witeck, et al.
Published: (2022-01-01) -
THE DISEASE IS THE ACCUMULATION OF CHOLESTEROL ESTERS DUE TO DEFICIT OF LYSOSOMAL ACID LIPASE. CLINICAL CASE OF LYSOSOMAL ACID LIPASE DEFICIENCY IS DESCRIBED IN THIS ARTICLE
by: S. A. Loskutova, et al.
Published: (2018-02-01) -
Persistent dyslipidemia in treatment of lysosomal acid lipase deficiency
by: Amanda Barone Pritchard, et al.
Published: (2020-02-01)